Gen9 is the premier next-generation gene synthesis company focused on high-quality, high-throughput, automated production of DNA constructs. Currently, Gen9 offers multiple synthetic biology solutions for researchers who need high quality clonal, sequence-perfect DNA. Our award winning BioFab® process is remarkably flexible and very high throughput; allowing us to make the genes you need quickly at the highest quality available. Gen9 is Powering the Synthetic Biology Revolution.
|Size (employees)||8 (est)|
Gen9 total Funding
Gen9 latest funding size
Time since last funding
|4 years ago|
|Agilent TechnologiesDraper Fisher Jurvetson (DFJ)|
Gen9 has 2.84k Twitter Followers. The number of followers has decreased 0.1% month over month and decreased 0.3% quarter over quarter